IL1B and in situ carcinoma: According to the output results, IL-1β and IL-6 as well as MDA were all independent risk factors of HT in CIS patients after IT (all P < 0.05), while Apelin, Vaspin, and SOD were independent protective factors (all P < 0.05) (Table 3).